Description
Cardiovascular disease remains the leading cause of death worldwide, responsible for roughly 1 in 3 deaths globally (19-20 million in 2023), yet population screening tools are still underused, especially in low- and middle-income countries, where studies show fewer than half of people who qualify for basic treatments like blood pressure medication are actually receiving them. In this video, experts discuss how AI-enhanced ECGs could support cardiovascular screening, help clinicians identify heart disease earlier and create new opportunities for preventive cardiology.
Learn how AI-enabled ECG technology could help transform routine electrocardiograms into scalable screening opportunities.
Learn more: https://www.gehealthcare.com/en-us/products/diagnostic-ecg/resting-ecg?utm_source=youtube&utm_campaign=USC-USC-PCS-DCR-AlwaysOn-AWR-SM-26-05&utm_medium=video&utm_content=interviews&utm_term=organic
#ECG #CardiacScreening #Cardiology #PreventiveCardiology #CardiovascularDisease
WHO, The Top 10 Causes of Death — who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
Global Burden of Disease Study 2023 (via ACC) — acc.org/latest-in-cardiology/journal-scans/2025/09/24/21/17/new-global-burden
PLOS Medicine, CVD risk profile and management in 45 LMICs — journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1003485
Frontiers in Public Health, Cost-effectiveness of population CVD screening — frontiersin.org/journals/public-health/articles/10.3389/fpubh.2022.820750/full